UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

AIFA time-to-reimbursement: a comparison between the last two committees from 2015 to 2020

Global & regional health technology assessment (Online), 2020-12, Vol.7 (1), p.109-114

2020

Volltextzugriff (PDF)

Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB

Glia, 2013-07, Vol.61 (7), p.1134-1145

2013

Volltextzugriff (PDF)

The antitripanocide Benznidazole promotes adaptive response to oxidative injury: Involvement of the nuclear factor-erythroid 2-related factor-2 (Nrf2) and multidrug resistance associated protein 2 (MRP2)

Toxicology and applied pharmacology, 2016-08, Vol.304, p.90-98

2016

Volltextzugriff (PDF)

Differential deregulation of astrocytic calcium signalling by amyloid-β, TNFα, IL-1β and LPS

Cell calcium (Edinburgh), 2014-04, Vol.55 (4), p.219-229

2014

Volltextzugriff (PDF)

Effectiveness of physicochemical techniques on the activation of Ti6Al4V surface with improved biocompatibility and antibacterial properties

Surface & coatings technology, 2022-10, Vol.447, p.128821, Article 128821

2022

Volltextzugriff (PDF)

Evaluation of both neutrophil migration and the relative frequency of CD4+/CD8+ limphocytes in children with Down syndrome and controls

Scientia medica, 2015, Vol.25 (1)

2015

Volltextzugriff (PDF)

Glial calcium signalling in Alzheimer's disease

Reviews of physiology, biochemistry and pharmacology, 2014-01, Vol.167, p.45

2014

Volltextzugriff (PDF)

A novel Ca2+ -mediated cross-talk between endoplasmic reticulum and acidic organelles: Implications for NAADP-dependent Ca2+ signalling

Cell calcium (Edinburgh), 2015-02, Vol.57 (2), p.89-100

2015

Volltextzugriff (PDF)

Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?

Journal of pharmaceutical policy and practice, 2021-03, Vol.14 (1), p.30, Article 30

2021

Volltextzugriff (PDF)

Primary Biliary Cholangitis: advances in management and treatment of the disease

Digestive and liver disease, 2017-08, Vol.49 (8), p.841-846

2017

Volltextzugriff (PDF)

Sentinel lymph node dissection in stage I/II melanoma patients: surgical management and clinical follow-up study

Melanoma research, 2004-04, Vol.14 (2), p.S9-S12

2004

Volltextzugriff (PDF)

Sequential Treatment with Tacrolimus and Rituximab vs. Alternating Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy (PMN): FR-OR53

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.B1-B2

2020

Volltextzugriff (PDF)

The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

Kidney international, 2021-04, Vol.99 (4), p.986-998

2021

Volltextzugriff (PDF)

Tempi di accesso ai farmaci in Italia nel periodo 2015-2017: Analisi delle tempistiche di valutazione dell’Agenzia Italiana del Farmaco

Global & regional health technology assessment (Online), 2018-01, Vol.2018

2018

Volltextzugriff (PDF)

Tempi di accesso ai farmaci in Italia nel periodo 2015-2017: Analisi delle tempistiche di valutazione dell’Agenzia Italiana del Farmaco

Global & regional health technology assessment (Online), 2018-08, Vol.5 (1)

2018

Volltextzugriff (PDF)

Tempi di accesso ai farmaci in Italia nel periodo 2015-2017: Analisi delle tempistiche di valutazione dell’Agenzia Italiana del Farmaco

Global & regional health technology assessment (Online), 2018-01, Vol.2018, p.228424031879244

2018

Volltextzugriff (PDF)

Le tempistiche autorizzative di AIFA: un confronto tra le due commissioni consultive e tecnico-scientifiche succedutesi nel periodo 2015-2020

Global & regional health technology assessment (Online), 2020-12, Vol.7, p.109-114

2020

Volltextzugriff (PDF)

The trypanocidal benznidazole promotes adaptive response to oxidative injury: Involvement of the nuclear factor-erythroid 2-related factor-2 (Nrf2) and multidrug resistance associated protein 2 (MRP2)

Toxicology and applied pharmacology, 2016-08, Vol.304, p.90-98

2016

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

AIFA time-to-reimbursement: a comparison between the last two committees from 2015 to 2020

Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB

The antitripanocide Benznidazole promotes adaptive response to oxidative injury: Involvement of the nuclear factor-erythroid 2-related factor-2 (Nrf2) and multidrug resistance associated protein 2 (MRP2)

Differential deregulation of astrocytic calcium signalling by amyloid-β, TNFα, IL-1β and LPS

Effectiveness of physicochemical techniques on the activation of Ti6Al4V surface with improved biocompatibility and antibacterial properties

Evaluation of both neutrophil migration and the relative frequency of CD4+/CD8+ limphocytes in children with Down syndrome and controls

Glial calcium signalling in Alzheimer's disease

A novel Ca2+ -mediated cross-talk between endoplasmic reticulum and acidic organelles: Implications for NAADP-dependent Ca2+ signalling

Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?

Primary Biliary Cholangitis: advances in management and treatment of the disease

Sentinel lymph node dissection in stage I/II melanoma patients: surgical management and clinical follow-up study

Sequential Treatment with Tacrolimus and Rituximab vs. Alternating Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy (PMN): FR-OR53

The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

Tempi di accesso ai farmaci in Italia nel periodo 2015-2017: Analisi delle tempistiche di valutazione dell’Agenzia Italiana del Farmaco

Tempi di accesso ai farmaci in Italia nel periodo 2015-2017: Analisi delle tempistiche di valutazione dell’Agenzia Italiana del Farmaco

Tempi di accesso ai farmaci in Italia nel periodo 2015-2017: Analisi delle tempistiche di valutazione dell’Agenzia Italiana del Farmaco

Le tempistiche autorizzative di AIFA: un confronto tra le due commissioni consultive e tecnico-scientifiche succedutesi nel periodo 2015-2020

The trypanocidal benznidazole promotes adaptive response to oxidative injury: Involvement of the nuclear factor-erythroid 2-related factor-2 (Nrf2) and multidrug resistance associated protein 2 (MRP2)

Suchergebnisse filtern